We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Cell Adhesion · CPC catalog code RGDP-007
This sequence carries terminal or reporter modifications (Ac, NH2), so no molecular formula or weight is published here — the modified mass must come from the lot certificate of analysis. Residue composition and charge describe the peptide backbone only. Composition figures above are derived arithmetically from the published sequence for the unmodified free peptide. Salt forms (commonly trifluoroacetate or acetate), amidation, and other modifications shift the observed mass — always reconcile against the current lot certificate of analysis.
Volumes for a 1 mg vial of Integrin Binding Peptide at common working concentrations. Add solvent slowly down the vial wall and swirl — do not vortex or shake.
Reference standards in the Cell Adhesion class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
Integrin Binding Peptide sits within the Cell Adhesion research class (CPC reference RGDP-007). Cell-adhesion peptides present short recognition motifs (RGD, YIGSR, IKVAV, and related sequences) that engage integrins and matrix receptors, allowing controlled studies of attachment, spreading, migration, and outside-in signaling. Investigators typically incorporate Integrin Binding Peptide as a reference standard, tool ligand, or substrate in the assay contexts listed above. Typically used in coated-plate attachment assays, transwell migration, and SPR / BLI integrin-binding measurements.
Integrin Binding Peptide (CPC catalog code RGDP-007) is a synthetic cell adhesion / ecm peptide in the cell adhesion category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use Integrin Binding Peptide as a reference standard in cell adhesion workflows — for example, integrin engagement and blocking studies and migration and wound-closure assays. Human clinical evidence is not established.
No. Integrin Binding Peptide is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a cell adhesion workflow, Integrin Binding Peptide is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Typically used in coated-plate attachment assays, transwell migration, and SPR / BLI integrin-binding measurements.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.